Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
3.290
+0.070 (2.17%)
At close: Jun 27, 2025, 4:00 PM
3.370
+0.080 (2.43%)
After-hours: Jun 27, 2025, 7:58 PM EDT
Lipocine Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Lipocine stock ranges from a low of $8.00 to a high of $10. The average analyst price target of $9.00 forecasts a 173.56% increase in the stock price over the next year.
Price Target: $9.00 (+173.56%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Lipocine stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +143.16% | Jun 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +143.16% | Jun 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +143.16% | May 29, 2025 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +203.95% | Sep 24, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $33 | Buy | Reiterates | $33 | +903.04% | Jul 27, 2023 |
Financial Forecast
Revenue This Year
1.23M
from 11.20M
Decreased by -89.04%
Revenue Next Year
571.20K
from 1.23M
Decreased by -53.45%
EPS This Year
-1.89
from -0.00
EPS Next Year
-1.48
from -1.89
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.3M | 756,000 | 1.3M | ||
| Avg | 1.2M | 571,200 | 1.2M | ||
| Low | 1.2M | 392,000 | 1.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -88.7% | -38.4% | 120.6% | ||
| Avg | -89.0% | -53.4% | 114.3% | ||
| Low | -89.5% | -68.1% | 105.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.94 | -1.52 | -1.16 |
| Avg | -1.89 | -1.48 | -1.12 |
| Low | -1.81 | -1.42 | -1.08 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.